By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...

A clinical trial shows that a specific probiotic blend reduced fever duration by 48 hours in children with respiratory ...

Research found that following a ketogenic diet for 6 months can reprogram immune cell metabolism and promote ...

Pembrolizumab and XL888 in advanced CRC showed manageable safety, though limited responses and potential immunomodulatory ...

A growth factor-stimulating gene therapy did not improve outcomes with vascularized lymph node transfer (VLNT) for breast ...

Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...

EVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics ...

Recent advancements in endometriosis research are transforming treatment, focusing on non-surgical interventions and ...

A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...